Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colonic Neoplasms × Radiography, Panoramic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 1

Interventions

Fluorouracil 64 Leucovorin 62 Oxaliplatin 43 Irinotecan 28 Folfox protocol 20 Bevacizumab 20 Capecitabine 19 Cetuximab 13 Chemotherapy, Adjuvant 11 Aspirin 6 Laparoscopy 5 Celecoxib 5 XELOX 4 Panitumumab 4 Levamisole 4 dehydroftorafur 3 Observation 3 Floxuridine 3 tislelizumab 2 pertuzumab 2 encorafenib 2 atezolizumab 2 Trastuzumab 2 Tegafur 2 Surgical Procedures, Operative 2 Standard of Care 2 Semaxinib 2 Octreotide 2 Occult Blood 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00002968 2025-12-29

Edrecolomab in Treating Patients With Stage II Colon Cancer

National Cancer Institute (NCI)

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡